Novel alternatively spliced variant with a deletion of 52 BP in exon 6 of the progesterone receptor gene is observed frequently in breast cancer tissues

No abstract is available for this paper.

• Publication year

  2003

• Venue

  International Journal of Cancer

• Publication date

  2003-06-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.11050PMID 12673676
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of a novel splicing variant deleting exons 4 and 6 of the progesterone receptor gene is a rare event in breast cancer.

  2003cited by this paper
• ARHI/NOEY2 Inactivation May Be Important in Breast Tumor Pathogenesis

  2002cited by this paper
• ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers

  2000cited by this paper
• Nonsense-mediated mRNA decay in health and disease.

  1999cited by this paper
• Alternative splicing of human genes: more the rule than the exception?

  1999cited by this paper
• Frequent alternative splicing of human genes.

  1999cited by this paper
• An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non‐familial breast cancers

  1998cited by this paper
• Progesterone receptor variants found in breast cells repress transcription by wild-type receptors

  1998cited by this paper
• Association of a human G-protein β3 subunit variant with hypertension

  1998cited by this paper
• Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome

  1997cited by this paper
• Mutations of the Ki‐ras, p53 and APC genes in adenocarcinomas of the human small intestine

  1997cited by this paper
• Identification of novel exon-deleted progesterone receptor variant mRNAs in human breast tissue.

  1996cited by this paper
• Alternative splicing of exon 3 of the human growth hormone receptor is the result of an unusual genetic polymorphism.

  1996cited by this paper
• Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: A review

  1996cited by this paper
• Telomerase activity in human breast cancer and benign breast lesions: Diagnostic applications in clinical specimens, including fine needle aspirates

  1996cited by this paper
• Characterization of progesterone receptor A and B expression in human breast cancer.

  1995cited by this paper
• Specific progesterone receptors in human breast cancer.

  1975cited by this paper
• Estrogen and progestogen binders in human and rat mammary carcinoma.

  1973cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Coexpression of Alternatively Spliced Estrogen and Progesterone Receptor Transcripts in Human Breast Cancer*

  year unknowncited by this paper

• Progesterone Control of Myometrial Contractility.

  2023cites this paper
• Alternative Splicing in the Nuclear Receptor Superfamily Redirects Human Metabolic Homeostasis

  2020cites this paper
• Alternative Splicing in the Nuclear Receptor Superfamily Expands Gene Function to Refine Endo-Xenobiotic Metabolism

  2020cites this paper
• Genetic and mechanistic analysis of rat mammary cancer susceptibility.

  2014cites this paper
• Alternative splicing of the nuclear progestin receptor in a perciform teleost generates novel mechanisms of dominant-negative transcriptional regulation.

  2013cites this paper
• Alternative splicing and its role in pathologies of the endocrine system.

  2011cites this paper
• A study to investigate the expression, structure and function of alternatively spliced progesterone receptor variants in breast cancer cells

  2011cites this paper
• Alternative splicing and its role in pathologies of the endocrine system Różnicowe składanie pierwotnego transkryptu w patologiach układu endokrynnego

  2011cites this paper
• Changes of the Alternative Splicing Variants of Human Telomerase Reverse Transcriptase during Gastric Carcinogenesis

  2009cites this paper
• Systematic expression analysis and antibody screening do not support the existence of naturally occurring progesterone receptor (PR)-C, PR-M, or other truncated PR isoforms.

  2008cites this paper
• Identification of alternative splicing markers for breast cancer.

  2008cites this paper
• Alternative splicing and the progesterone receptor in breast cancer

  2008cites this paper
• Zyklusabhängige Expression und Lokalisation der Isoform C des Progesteronrezeptors im humanen Endometrium im Vergleich mit den Isoformen B und A

  2008cites this paper
• RNA regulation and cancer development.

  2007cites this paper
• Variant progesterone receptor mRNAs are co-expressed with the wild-type progesterone receptor mRNA in human endometrium during all phases of the menstrual cycle.

  2005influential citation
• Myometrial Progesterone responsiveness and the Control of Human Parturition

  2004cites this paper
• Identification of an alternative splicing transcript for the resistin gene and distribution of its mRNA in human tissue.

  2004cites this paper
• Estrogen and progesterone receptor isoforms: clinical significance in breast cancer

  2004cites this paper
• Mechanisms Underlying “Functional” Progesterone Withdrawal at Parturition

  2004cites this paper
• Aberrant and Alternative Splicing in Cancer

  2004cites this paper
• Expression profile of a gamma-deletion variant of the human telomerase reverse transcriptase gene.

  2003cites this paper